Enhancing Stability and Jumping Skills Through Combined Static and Dynamic Balance Training in Female Chinese University-Level Gymnastics Beginners

February 1, 2026 updated by: Yi Wang
This study aims to investigate the effects of different balance training programs (dynamic, static, combined dynamic and static) on the stability, jumping skills, and gymnastic movement skills of female university students who are beginners in gymnastics. Participants will be randomly divided into four groups: the first group will receive dynamic balance training (including exercises that maintain balance during movement); the second group will receive static balance training (including exercises that hold a fixed posture); the third group will receive combined dynamic and static balance training (including both static and dynamic balance exercises); and the fourth group will serve as a control group without additional balance training (or receive regular physical education classes as a control). The main outcomes to be measured before and after the training period are the participants' performance in specific stability tests, jumping tasks, and gymnastic movement skill assessments. The goal is to determine which balance training method (dynamic, static, or combined training) is most effective in improving the fundamental movement skills (including gymnastics-specific abilities) of gymnastics beginners.

Study Overview

Status

Status

Indicates the current recruitment status or the expanded access status.
Completed

Conditions

Conditions

The disease, disorder, syndrome, illness, or injury that is being studied. On ClinicalTrials.gov, conditions may also include other health-related issues, such as lifespan, quality of life, and health risks.

Intervention / Treatment

Intervention / Treatment

A process or action that is the focus of a clinical study. Interventions include drugs, medical devices, procedures, vaccines, and other products that are either investigational or already available. Interventions can also include noninvasive approaches, such as education or modifying diet and exercise.

Study Type

Study Type

Describes the nature of a clinical study. Study types include interventional studies (also called clinical trials), observational studies (including patient registries), and expanded access.
Interventional

Enrollment (Actual)

Enrollment

The number of participants in a clinical study. The "anticipated" enrollment is the target number of participants that the researchers need for the study.
60

Phase

Phase

The stage of a clinical trial studying a drug or biological product, based on definitions developed by the U.S. Food and Drug Administration (FDA). The phase is based on the study's objective, the number of participants, and other characteristics. There are five phases: Early Phase 1 (formerly listed as Phase 0), Phase 1, Phase 2, Phase 3, and Phase 4. Not Applicable is used to describe trials without FDA-defined phases, including trials of devices or behavioral interventions.
  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • China
      • Beijing, China
        • Beijing Sport University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Eligibility Criteria

The key requirements that people who want to participate in a clinical study must meet or the characteristics they must have. Eligibility criteria consist of both inclusion criteria (which are required for a person to participate in the study) and exclusion criteria (which prevent a person from participating). Types of eligibility criteria include whether a study accepts healthy volunteers, has age or age group requirements, or is limited by sex.

Ages Eligible for Study

  • Adult

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  1. Females
  2. Age ranged between 18 -22 years old, normal body mass index (BMI) (18.5 -25kg/m²).
  3. Undergraduate students of physical education at Beijing Sport University.
  4. No prior systematic gymnastics training (or with ≤ 1 year of systematic training experience), and no history of congenital diseases or musculoskeletal injuries.

Exclusion Criteria:

  1. Participants suffering from acute or chronic musculoskeletal injuries (lasting for 6 months or more), neurological disorders (such as epilepsy), or vestibular dysfunction.
  2. Ranked athletes or elite athletes.
  3. Participants with poor compliance (< 80%) who are unable to complete the 8 - week exercise intervention program.
  4. Individuals who have recently undergone or are scheduled to undergo surgery within three months.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Other
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm

Participant Group / Arm

A group or subgroup of participants in a clinical trial that receives a specific intervention/treatment, or no intervention, according to the trial's protocol.
Intervention / Treatment

Intervention / Treatment

A process or action that is the focus of a clinical study. Interventions include drugs, medical devices, procedures, vaccines, and other products that are either investigational or already available. Interventions can also include noninvasive approaches, such as education or modifying diet and exercise.
Active Comparator: Control group
Behavioral: balance group
An 8-week supervised training program conducted 2 times per week. Each 15-30 minute session comprises a combination of static balance exercises , dynamic balance exercises and Combining training. The intensity and difficulty of the exercises will be progressively increased throughout the intervention period.
Experimental: Static balance group
Behavioral: balance group
An 8-week supervised training program conducted 2 times per week. Each 15-30 minute session comprises a combination of static balance exercises , dynamic balance exercises and Combining training. The intensity and difficulty of the exercises will be progressively increased throughout the intervention period.
Experimental: Dynamic balance group
Behavioral: balance group
An 8-week supervised training program conducted 2 times per week. Each 15-30 minute session comprises a combination of static balance exercises , dynamic balance exercises and Combining training. The intensity and difficulty of the exercises will be progressively increased throughout the intervention period.
Experimental: Static and Dynamic balance group
Behavioral: balance group
An 8-week supervised training program conducted 2 times per week. Each 15-30 minute session comprises a combination of static balance exercises , dynamic balance exercises and Combining training. The intensity and difficulty of the exercises will be progressively increased throughout the intervention period.

What is the study measuring?

Primary Outcome Measures

Primary Outcome Measures

In a clinical study's protocol, the planned outcome measure that is the most important for evaluating the effect of an intervention/treatment. Most clinical studies have one primary outcome measure, but some have more than one.
Outcome Measure
Time Frame
The 8-point Star Offset (cm)
Time Frame: Baseline (pre-intervention) and at 8 weeks (immediately post-intervention)
Baseline (pre-intervention) and at 8 weeks (immediately post-intervention)
Jump Height (cm)
Time Frame: Baseline (pre-intervention) and at 8 weeks (immediately post-intervention)
Baseline (pre-intervention) and at 8 weeks (immediately post-intervention)
Peak Force (N)
Time Frame: Baseline (pre-intervention) and at 8 weeks (immediately post-intervention)
Baseline (pre-intervention) and at 8 weeks (immediately post-intervention)
Rate of Force Development (N·S)
Time Frame: Baseline (pre-intervention) and at 8 weeks (immediately post-intervention)
Baseline (pre-intervention) and at 8 weeks (immediately post-intervention)
Impulse (N·s)
Time Frame: Baseline (pre-intervention) and at 8 weeks (immediately post-intervention)
Baseline (pre-intervention) and at 8 weeks (immediately post-intervention)

Secondary Outcome Measures

Secondary Outcome Measures

In a clinical study's protocol, a planned outcome measure that is not as important as the primary outcome measure for evaluating the effect of an intervention but is still of interest. Most clinical studies have more than one secondary outcome measure.
Outcome Measure
Time Frame
Center of gravity deviation distance (mm)
Time Frame: Baseline (pre-intervention) and at 8 weeks (immediately post-intervention)
Baseline (pre-intervention) and at 8 weeks (immediately post-intervention)
Joint Angle variation (°)
Time Frame: Baseline (pre-intervention) and at 8 weeks (immediately post-intervention)
Baseline (pre-intervention) and at 8 weeks (immediately post-intervention)
Vertical Jump Efficiency (%)
Time Frame: Baseline (pre-intervention) and at 8 weeks (immediately post-intervention)
Baseline (pre-intervention) and at 8 weeks (immediately post-intervention)
Landing Impact Force (N)
Time Frame: Baseline (pre-intervention) and at 8 weeks (immediately post-intervention)
Baseline (pre-intervention) and at 8 weeks (immediately post-intervention)
Body Oscillation Amplitude (mm)
Time Frame: Baseline (pre-intervention) and at 8 weeks (immediately post-intervention)
Baseline (pre-intervention) and at 8 weeks (immediately post-intervention)
Rotation Smoothness Index (°)
Time Frame: Baseline (pre-intervention) and at 8 weeks (immediately post-intervention)
Baseline (pre-intervention) and at 8 weeks (immediately post-intervention)
Height (cm)
Time Frame: Baseline (pre-intervention) and at 8 weeks (immediately post-intervention)
Baseline (pre-intervention) and at 8 weeks (immediately post-intervention)
Weight (kg)
Time Frame: Baseline (pre-intervention) and at 8 weeks (immediately post-intervention)
Baseline (pre-intervention) and at 8 weeks (immediately post-intervention)
BMI (kg/m2)
Time Frame: Baseline (pre-intervention) and at 8 weeks (immediately post-intervention)
Baseline (pre-intervention) and at 8 weeks (immediately post-intervention)

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Sponsor

The organization or person who initiates the study and who has authority and control over the study.
Yi Wang

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Helpful Links

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

Study Start

The actual date on which the first participant was enrolled in a clinical study. The "anticipated" study start date is the date that the researchers think will be the study start date.
November 6, 2025

Primary Completion (Actual)

Primary Completion

The date on which the last participant in a clinical study was examined or received an intervention to collect final data for the primary outcome measure. Whether the clinical study ended according to the protocol or was terminated does not affect this date. For clinical studies with more than one primary outcome measure with different completion dates, this term refers to the date on which data collection is completed for all the primary outcome measures. The "anticipated" primary completion date is the date that the researchers think will be the primary completion date for the study.
January 20, 2026

Study Completion (Actual)

Study Completion

The date on which the last participant in a clinical study was examined or received an intervention/treatment to collect final data for the primary outcome measures, secondary outcome measures, and adverse events (that is, the last participant's last visit). The "anticipated" study completion date is the date that the researchers think will be the study completion date.
January 20, 2026

Study Registration Dates

First Submitted

First Submitted

The date on which the study sponsor or investigator first submitted a study record to ClinicalTrials.gov. There is typically a delay of a few days between the first submitted date and the record's availability on ClinicalTrials.gov (the first posted date).
November 15, 2025

First Submitted That Met QC Criteria

First Submitted That Met QC Criteria

The date on which the study sponsor or investigator first submits a study record that is consistent with National Library of Medicine (NLM) quality control (QC) review criteria. The sponsor or investigator may need to revise and submit a study record one or more times before NLM's QC review criteria are met. It is the responsibility of the sponsor or investigator to ensure that the study record is consistent with the NLM QC review criteria.
December 3, 2025

First Posted (Actual)

First Posted

The date on which the study record was first available on ClinicalTrials.gov after National Library of Medicine (NLM) quality control (QC) review has concluded. There is typically a delay of a few days between the date the study sponsor or investigator submitted the study record and the first posted date.
December 17, 2025

Study Record Updates

Last Update Posted (Actual)

Last Update Posted

The most recent date on which changes to a study record were made available on ClinicalTrials.gov. There may be a delay between when the changes were submitted to ClinicalTrials.gov by the study's sponsor or investigator (the last update submitted date) and the last update posted date.
February 3, 2026

Last Update Submitted That Met QC Criteria

Last Update Submitted That Met QC Criteria

The most recent date on which the study sponsor or investigator submitted changes to a study record that are consistent with National Library of Medicine (NLM) quality control (QC) review criteria. It is the responsibility of the sponsor or investigator to ensure that the study record is consistent with the NLM QC review criteria.
February 1, 2026

Last Verified

Last Verified

The most recent date on which the study sponsor or investigator confirmed the information about a clinical study on ClinicalTrials.gov as accurate and current. If a study with a recruitment status of recruiting; not yet recruiting; or active, not recruiting has not been confirmed within the past 2 years, the study's recruitment status is shown as unknown.
February 1, 2026

More Information

Terms related to this study

Other Study ID Numbers

Other Study ID Numbers

Identifiers or ID numbers other than the NCT number that are assigned to a clinical study by the study's sponsor, funders, or others. These numbers may include unique identifiers from other trial registries and National Institutes of Health grant numbers.
  • USM/JEPeM/KK/25070591

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

YES

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Cookie Settings

We use cookies to ensure that we give you the best experience on our website. For more details carefully read our Privacy and Cookies Policy. ...>>>You can change your preferences or withdraw your consent at any time by deleting the cookies from your website or computer as described in the policy. Please accept it and choose your preferences by ticking the corresponding boxes in the "Manage Settings" section below. Please carefully read our Terms of Service before you proceed with using any part of this website.
«Manage Settings